Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Reduced triclosan susceptibility in methicillin-resistant Staphylococcus epidermidis.

Schmid MB, Kaplan N.

Antimicrob Agents Chemother. 2004 Apr;48(4):1397-9.

2.
3.

[Reduced susceptibility to triclosan in methicillin-resistant Staphylococcus aureus].

Wiśniewska K, Piechowicz L, Galiński J.

Med Dosw Mikrobiol. 2006;58(1):11-7. Polish.

PMID:
16871968
4.

Small-colony variants: a novel mechanism for triclosan resistance in methicillin-resistant Staphylococcus aureus.

Seaman PF, Ochs D, Day MJ.

J Antimicrob Chemother. 2007 Jan;59(1):43-50. Epub 2006 Oct 31.

5.

Staphylococcus epidermidis isolated in 1965 are more susceptible to triclosan than current isolates.

Skovgaard S, Nielsen LN, Larsen MH, Skov RL, Ingmer H, Westh H.

PLoS One. 2013 Apr 16;8(4):e62197. doi: 10.1371/journal.pone.0062197. Print 2013.

6.

Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA).

Brenwald NP, Fraise AP.

J Hosp Infect. 2003 Oct;55(2):141-4.

PMID:
14529640
7.

Comment on: Triclosan resistance in methicillin-resistant Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of susceptibility to antiseptics.

Seaman PF, Ochs D, Day MJ.

J Antimicrob Chemother. 2007 Jul;60(1):175-6; author reply 176-7. Epub 2007 May 4. No abstract available.

8.

Activity of clindamycin against Staphylococcus aureus and Staphylococcus epidermidis from four UK centres.

Reeves DS, Holt HA, Phillips I, King A, Miles RS, Paton R, Wise R, Andrews JM.

J Antimicrob Chemother. 1991 Apr;27(4):469-74.

PMID:
1856126
9.

Triclosan and antibiotic resistance in Staphylococcus aureus.

Suller MT, Russell AD.

J Antimicrob Chemother. 2000 Jul;46(1):11-8.

10.
12.
13.

In vitro activity of gallium maltolate against Staphylococci in logarithmic, stationary, and biofilm growth phases: comparison of conventional and calorimetric susceptibility testing methods.

Baldoni D, Steinhuber A, Zimmerli W, Trampuz A.

Antimicrob Agents Chemother. 2010 Jan;54(1):157-63. doi: 10.1128/AAC.00700-09. Epub 2009 Oct 5.

14.
15.

[Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].

Fajardo Olivares M, Hidalgo Orozco R, Rodríguez Garrido S, Gaona Álvarez C, Sánchez Silos RM, Hernández Rastrollo R, Martínez Tallo E, Cordero Carrasco JL.

Rev Esp Quimioter. 2012 Mar;25(1):25-30. Spanish.

16.
17.

Identification, clinical distribution, and susceptibility to methicillin and 18 additional antibiotics of clinical Staphylococcus isolates: nationwide investigation in Italy.

Varaldo PE, Cipriani P, Focá A, Geraci C, Giordano A, Madeddu MA, Orsi A, Pompei R, Prenna M, Repetto A, et al.

J Clin Microbiol. 1984 Jun;19(6):838-43.

18.
19.
20.

Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus.

Fan F, Yan K, Wallis NG, Reed S, Moore TD, Rittenhouse SF, DeWolf WE Jr, Huang J, McDevitt D, Miller WH, Seefeld MA, Newlander KA, Jakas DR, Head MS, Payne DJ.

Antimicrob Agents Chemother. 2002 Nov;46(11):3343-7.

Items per page

Supplemental Content

Write to the Help Desk